Evidence map›Paper›PMID 26376914›Full record

ArticleBMC gastroenterology2015

Altered intestinal functions and increased local inflammation in insulin-resistant obese subjects: a gene-expression profile analysis.

Alain Veilleux, Sylvain Mayeur, Jean-Christophe Bérubé, Jean-François Beaulieu, Eric Tremblay, Frédéric-Simon Hould, Yohan Bossé, Denis Richard, Emile Levy

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Enhanced gastrointestinal passive paracellular permeability contributes to the obesity-associated hyperoxaluria.American journal of physiology. Gastrointestinal and liver physiology · 2019
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Alain VeilleuxDepartment of Nutrition, Université de Montréal and Research center of CHU Sainte-Justine, 3175 Côte Ste-Catherine, Montréal, Qc, Canada. alain.veilleux@fsaa.ulaval.ca.
Sylvain MayeurDepartment of Nutrition, Université de Montréal and Research center of CHU Sainte-Justine, 3175 Côte Ste-Catherine, Montréal, Qc, Canada. sylvainmayeur@yahoo.fr.
Jean-Christophe BérubéInstitut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Québec, Qc, Canada. jean-christophe.berube@criucpq.ulaval.ca.
Jean-François BeaulieuDepartement of Anatomy and cellular biology, Université de Sherbrooke, Sherbrooke, Qc, Canada. Jean-Francois.Beaulieu@usherbrooke.ca.
Eric TremblayDepartement of Anatomy and cellular biology, Université de Sherbrooke, Sherbrooke, Qc, Canada. Eric.Tremblay@usherbrooke.ca.
Frédéric-Simon HouldInstitut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Québec, Qc, Canada. frederic.hould@chg.ulaval.ca.
Yohan BosséInstitut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Québec, Qc, Canada. yohan.bosse@criucpq.ulaval.ca.
Denis RichardInstitut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Québec, Qc, Canada. Denis.Richard@criucpq.ulaval.ca.
Emile LevyDepartment of Nutrition, Université de Montréal and Research center of CHU Sainte-Justine, 3175 Côte Ste-Catherine, Montréal, Qc, Canada. emile.levy@recherche-ste-justine.qc.ca.
Université de Montréal · CAUniversité Laval · CAUniversité de Sherbrooke · CAInstitut Universitaire de Cardiologie et de Pneumologie de Québec · CA

Funding

Canadian Institutes of Health Research MOP 10584Canadian Institutes of Health Research MOP 49433
6 · The paper itself

Abstract

backgroundMetabolic alterations relevant to postprandial dyslipidemia were previously identified in the intestine of obese insulin-resistant subjects. The aim of the study was to identify the genes deregulated by systemic insulin resistance in the intestine of severely obese subjects.

methodsTranscripts from duodenal samples of insulin-sensitive (HOMA-IR < 3, n = 9) and insulin-resistant (HOMA-IR > 7, n = 9) obese subjects were assayed by microarray (Illumina HumanHT-12).

resultsA total of 195 annotated genes were identified as differentially expressed between these two groups (Fold change > 1.2). Of these genes, 36 were found to be directly involved in known intestinal functions, including digestion, extracellular matrix, endocrine system, immunity and cholesterol metabolism. Interestingly, all differentially expressed genes (n = 8) implicated in inflammation and oxidative stress were found to be upregulated in the intestine of insulin-resistant compared to insulin-sensitive subjects. Metabolic pathway analysis revealed that several signaling pathways involved in immunity and inflammation were significantly enriched in differently expressed genes and were predicted to be activated in the intestine of insulin-resistant subjects. Using stringent criteria (Fold change > 1.5; FDR < 0.05), three genes were found to be significantly and differently expressed in the intestine of insulin-resistant compared to insulin-sensitive subjects: the transcripts of the insulinotropic glucose-dependant peptide (GIP) and of the β-microseminoprotein (MSMB) were significantly reduced, but that of the humanin like-1 (MTRNR2L1) was significantly increased.

conclusionThese results underline that systemic insulin resistance is associated with remodeling of key intestinal functions. Moreover, these data indicate that small intestine metabolic dysfunction is accompanied with a local amplification of low-grade inflammatory process implicating several pathways. Genes identified in this study are potentially triggered throughout the development of intestinal metabolic abnormalities, which could contribute to dyslipidemia, a component of metabolic syndrome and diabetes.

Indexed as

Gene ExpressionAdultCaco-2 CellsDuodenumFemaleGastric Inhibitory PolypeptideGene Expression ProfilingHumansInflammationInsulin ResistanceIntercellular Signaling Peptides and ProteinsMaleMicroarray AnalysisObesityOxidative StressProstatic Secretory Proteinsbeta-microseminoproteinGastric Inhibitory PolypeptideIntercellular Signaling Peptides and ProteinsMTRNR2L1 protein, humanProstatic Secretory ProteinsProteinsRNA, Messenger

Identifiers

PMID26376914
PMCPMC4574092
OpenAlexW2151706818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.